STOCK TITAN

Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Cibus (Nasdaq: CBUS) has completed initial field tests of its Pod Shatter Reduction (PSR) trait in winter oilseed rape in the UK, marking the first gene-edited trait to complete such trials in the country. The promising results support Cibus' ongoing commercial development of the PSR trait. This milestone was made possible by simplified UK regulations introduced in 2022, allowing for science-based testing of gene-edited traits.

Cibus utilizes its proprietary Rapid Trait Development System™ (RTDS®) to develop complex gene-edited traits. The PSR trait aims to address potential yield losses of 5% to 25% due to pod shatter in winter oilseed rape. The successful trials pave the way for a second season of testing, with Cibus looking to deliver the benefits of precision breeding to UK farmers and the broader European agricultural community.

Loading...
Loading translation...

Positive

  • Successful completion of initial field trials for Pod Shatter Reduction trait in UK winter oilseed rape
  • Promising results support continued commercial development of PSR trait
  • Potential to address yield losses of 5% to 25% in winter oilseed rape due to pod shatter
  • Second season of trials already underway

Negative

  • None.

News Market Reaction

+9.35%
1 alert
+9.35% News Effect

On the day this news was published, CBUS gained 9.35%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Initial data from Pod Shatter Reduction field trials show promising results

The first gene edited trait to complete field trials in oilseed rape in the UK

SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has completed initial field tests of its Pod Shatter Reduction (PSR) trait in the United Kingdom. The initial data from these trials support Cibus’ continuing commercial development of its PSR trait in winter oilseed rape. These trials represent an important progression in the Company’s commercial development with the application of Cibus’ spring oilseed rape (canola) PSR trait to winter oilseed rape.

Simplified rules, introduced in 2022 by the UK Department for the Environment, Food and Rural Affairs led to a science-based and streamlined regulatory approach that enabled Cibus’ PSR trait to be tested in winter oilseed rape under European growing conditions for the first time.

Cibus is a leader in the development of complex gene edited traits in plants like Pod Shatter Reduction in winter oilseed rape. The Company uses its proprietary Rapid Trait Development System™ (RTDS®), which includes techniques such as Gene Repair Oligonucleotides (GRON) and molecular scissors including Transcription activator-like effector nucleases (TALENs), to develop these traits.

Dr. Jim Radtke, Senior Vice President of Product Development at Cibus commented, “The results of these first PSR field trials in winter oilseed rape are very encouraging. We’ve been able to validate our existing PSR trait’s performance under controlled environments now in UK field conditions. These results pave the way for a second season of trials that are now underway.”

Tony Moran, Senior Vice President of International Development and Government Affairs at Cibus added, “Pod shatter in winter oilseed rape can impact growers’ productivity and national food security. With potential yield losses of 5% to 25%, we’re really excited to see our latest trait tested in European growing conditions. The completion of the first field trials in the UK is an important milestone for our European seed partners and winter oilseed rape farmers. We look forward to delivering the benefits of precision breeding tools to UK farmers and ultimately the broader European agriculture community.”

About Cibus

Cibus is a leading independent plant trait company that develops and licenses plant traits to seed companies for royalties. Cibus is not a seed company, but rather a technology company that uses its proprietary gene editing technology to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus’ strategy is focused on commercializing productivity traits for the world’s major row crops with large acreage such as: canola, rice, soybean, corn and wheat. The Company targets traits that help manage farmers’ seed productivity and sustainability challenges such as weeds, disease, and insects. The United Nations estimates that the impacts from these challenges cost the global economy approximately $300 billion annually. Cibus has a current portfolio of six traits, three of which are in commercial development and four of which are multi-crop traits associated with weed management and disease, including Sclerotinia resistance and a new weed management trait which are in advanced greenhouse and field trial stages.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "anticipates," "believes," "continue," "estimates," "expects," "intends," "may," "might," "plans," "predicts," "projects," "should," "targets," "will," or the negative of these terms and other similar terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated closing of the offering and the expected use of the proceeds from the offering. Completion of the offering is subject to numerous factors, many of which are beyond Cibus’ control, including, without limitation, market conditions, failure to satisfy customary closing conditions and the risk factors and other matters set forth in the prospectus supplement and accompanying prospectus included in the registration statement and the documents incorporated by reference therein. You are cautioned not to place undue reliance on any forward-looking statements made by Cibus’ management, which are based only on information currently available to it when, and speak only as of the date, such statement is made. Cibus does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.

CIBUS CONTACTS:

INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636

Jeff Sonnek – ICR
jeff.sonnek@icrinc.com

MEDIA RELATIONS
media@cibus.com
(619) 849-6009

Colin Sanford
colin@bioscribe.com
203-918-4347


FAQ

What is the significance of Cibus' Pod Shatter Reduction trait field trials in the UK?

Cibus' Pod Shatter Reduction (PSR) trait field trials in the UK are significant as they represent the first gene-edited trait to complete field trials in oilseed rape in the country. The trials validate the trait's performance under UK field conditions and support its commercial development for winter oilseed rape.

How could Cibus' PSR trait impact winter oilseed rape yields?

Cibus' Pod Shatter Reduction (PSR) trait has the potential to address yield losses of 5% to 25% in winter oilseed rape caused by pod shatter. This could significantly improve productivity for farmers and contribute to national food security.

What technology does Cibus (CBUS) use to develop its gene-edited traits?

Cibus uses its proprietary Rapid Trait Development System™ (RTDS®), which includes techniques such as Gene Repair Oligonucleotides (GRON) and molecular scissors like Transcription activator-like effector nucleases (TALENs), to develop complex gene-edited traits in plants.

When did the UK introduce simplified regulations for gene-edited crop trials?

The UK Department for the Environment, Food and Rural Affairs introduced simplified rules in 2022, leading to a science-based and streamlined regulatory approach that enabled Cibus' PSR trait to be tested in winter oilseed rape under European growing conditions.
CIBUS INC

NASDAQ:CBUS

CBUS Rankings

CBUS Latest News

CBUS Latest SEC Filings

CBUS Stock Data

98.04M
35.09M
33.53%
29%
2.37%
Biotechnology
Agricultural Chemicals
Link
United States
SAN DIEGO